[O2-01-05]: A placebo-controlled, double-blind trial of the selective AB-42 lowering agent, flurizan (MPC-7869, (R)-flurbiprofen) in patients with mild to moderate Alzheimer's disease
Keyword(s):
Keyword(s):
1998 ◽
Vol 854
(1 TOWARDS PROLO)
◽
pp. 508-509
◽
Keyword(s):
Keyword(s):
1990 ◽
Vol 5
(6)
◽
pp. 375-380
◽
Keyword(s):
1981 ◽
Vol 26
(6)
◽
pp. 426-428
◽
Keyword(s):
1981 ◽
Vol 138
(7)
◽
pp. 970-972
◽
Keyword(s):
1989 ◽
Vol 146
(1)
◽
pp. 45-49
◽
Keyword(s):
Keyword(s):